NCT07495605

Brief Summary

To compare the effect of 1% melatonin gel versus calcium hydroxide as intra canal medication in necrotic mandibular premolars on:

  • Intensity of postoperative pain.
  • Bacterial load reduction.
  • Periapical (MMP-9) level.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
19mo left

Started Mar 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Mar 2026Dec 2027

First Submitted

Initial submission to the registry

March 8, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

March 22, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

1.7 years

First QC Date

March 8, 2026

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intensity of postoperative pain

    Intensity of postoperative pain will be measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation

    up to 48 hours

Secondary Outcomes (2)

  • Bacterial load reduction

    intraoperative

  • Periapical MMP-9 level

    intraoperative

Study Arms (2)

calcium hydroxide

ACTIVE COMPARATOR

Calcium Hydroxide (Metapaste. META BIOMED CO., LTD, Korea): It is a water-soluble, premixed

Drug: Calcium Hydroxide (Ca(OH)2)

1% melatonin gel

EXPERIMENTAL

1% melatonin gel: was prepared in the Drug Manufacture Unit, Faculty of Pharmacy, Cairo university

Drug: 1% melatonin gel

Interventions

1% melatonin gel: was prepared in the Drug Manufacture Unit, Faculty of Pharmacy, Cairo university

1% melatonin gel

a water-soluble, premixed calcium hydroxide paste with barium sulfate, supplied in a 2.2g syringe

calcium hydroxide

Eligibility Criteria

Age21 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-50 years old.
  • Males and females.
  • Healthy patients categorized as I or II according to The American Society of Anesthesiologists. (ASA I or II), with no underlying allergies.
  • Single-rooted mandibular premolar teeth, having single root canal: diagnosed clinically with pulp necrosis.
  • Patients accepting to participate in the trial.
  • Patients who can understand pain scale (Appendix I) and can sign the informed consent (Appendix II).

You may not qualify if:

  • Medically compromised patients having significant systemic disorders (ASA III or IV).
  • Pregnant females.
  • If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively as it might alter their pain perception.
  • Teeth with multiple canals.
  • Teeth that show association with acute periapical abscess or swelling.
  • Teeth with vital pulp.
  • Non-restorable teeth or teeth that could not be adequately isolated with a rubber dam.
  • Immature teeth.
  • Teeth with greater than grade I mobility or pocket depth greater than 4 mm.
  • Teeth showing radiographic evidence of external or internal root resorption, vertical root fracture, perforation or calcification.
  • Patients with two or more adjacent teeth requiring endodontic treatment.
  • Patients reporting bruxism, clenching or TMJ problems.
  • Teeth with previous endodontic treatment.
  • Inability to perceive the given instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Calcium Hydroxide

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytes

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 8, 2026

First Posted

March 27, 2026

Study Start

March 22, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

March 27, 2026

Record last verified: 2026-03